

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug catabolic process (GO:0042737) | 9.70396468 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 9.10217898 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 9.04125785 |
| 4 | regulation of fibrinolysis (GO:0051917) | 8.48901561 |
| 5 | negative regulation of fibrinolysis (GO:0051918) | 8.37332142 |
| 6 | complement activation, alternative pathway (GO:0006957) | 8.32875202 |
| 7 | glyoxylate metabolic process (GO:0046487) | 8.02256070 |
| 8 | regulation of protein activation cascade (GO:2000257) | 7.68726484 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 7.62603817 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62603817 |
| 11 | regulation of complement activation (GO:0030449) | 7.20498464 |
| 12 | cellular glucuronidation (GO:0052695) | 7.02366849 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 6.99580895 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.99580895 |
| 15 | urea metabolic process (GO:0019627) | 6.99540266 |
| 16 | ethanol oxidation (GO:0006069) | 6.81848195 |
| 17 | fibrinolysis (GO:0042730) | 6.74333562 |
| 18 | glucuronate metabolic process (GO:0019585) | 6.67375814 |
| 19 | uronic acid metabolic process (GO:0006063) | 6.67375814 |
| 20 | drug metabolic process (GO:0017144) | 6.46337359 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 6.35656893 |
| 22 | oxidative demethylation (GO:0070989) | 6.29647151 |
| 23 | bile acid biosynthetic process (GO:0006699) | 6.27439273 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.20623484 |
| 25 | protein carboxylation (GO:0018214) | 6.20623484 |
| 26 | blood coagulation, intrinsic pathway (GO:0007597) | 5.95061707 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 5.77550959 |
| 28 | urea cycle (GO:0000050) | 5.74613366 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 5.57453418 |
| 30 | negative regulation of sterol transport (GO:0032372) | 5.50901175 |
| 31 | negative regulation of cholesterol transport (GO:0032375) | 5.50901175 |
| 32 | ethanol metabolic process (GO:0006067) | 5.49050862 |
| 33 | phenylpropanoid metabolic process (GO:0009698) | 5.28860043 |
| 34 | * bile acid metabolic process (GO:0008206) | 5.26555785 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 5.13794457 |
| 36 | regulation of plasminogen activation (GO:0010755) | 5.13311606 |
| 37 | glycine metabolic process (GO:0006544) | 5.11391592 |
| 38 | protein activation cascade (GO:0072376) | 5.04272506 |
| 39 | negative regulation of hemostasis (GO:1900047) | 4.94556185 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.94556185 |
| 41 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.81121029 |
| 42 | imidazole-containing compound metabolic process (GO:0052803) | 4.77631109 |
| 43 | S-adenosylmethionine metabolic process (GO:0046500) | 4.74282405 |
| 44 | complement activation (GO:0006956) | 4.73020799 |
| 45 | * bile acid and bile salt transport (GO:0015721) | 4.67852409 |
| 46 | complement activation, classical pathway (GO:0006958) | 4.61374786 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.57836395 |
| 48 | regulation of humoral immune response (GO:0002920) | 4.55229066 |
| 49 | negative regulation of protein activation cascade (GO:2000258) | 4.52576210 |
| 50 | negative regulation of coagulation (GO:0050819) | 4.49140242 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.46853014 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.46853014 |
| 53 | negative regulation of wound healing (GO:0061045) | 4.44312403 |
| 54 | alkaloid metabolic process (GO:0009820) | 4.40608016 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.33977000 |
| 56 | acute-phase response (GO:0006953) | 4.33445560 |
| 57 | hormone catabolic process (GO:0042447) | 4.31659196 |
| 58 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.28401112 |
| 59 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.26205153 |
| 60 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.26205153 |
| 61 | opsonization (GO:0008228) | 4.22012470 |
| 62 | positive regulation of hemostasis (GO:1900048) | 4.20497492 |
| 63 | positive regulation of blood coagulation (GO:0030194) | 4.20497492 |
| 64 | phospholipid efflux (GO:0033700) | 4.14228036 |
| 65 | cytolysis (GO:0019835) | 4.13135518 |
| 66 | tryptophan catabolic process (GO:0006569) | 4.13059529 |
| 67 | indole-containing compound catabolic process (GO:0042436) | 4.13059529 |
| 68 | indolalkylamine catabolic process (GO:0046218) | 4.13059529 |
| 69 | daunorubicin metabolic process (GO:0044597) | 4.11409350 |
| 70 | polyketide metabolic process (GO:0030638) | 4.11409350 |
| 71 | doxorubicin metabolic process (GO:0044598) | 4.11409350 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 4.06226923 |
| 73 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.04382138 |
| 74 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.98428576 |
| 75 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.98428576 |
| 76 | heme transport (GO:0015886) | 3.96090892 |
| 77 | flavonoid metabolic process (GO:0009812) | 3.95772102 |
| 78 | arginine metabolic process (GO:0006525) | 3.93644338 |
| 79 | plasma lipoprotein particle remodeling (GO:0034369) | 3.90645746 |
| 80 | protein-lipid complex remodeling (GO:0034368) | 3.90645746 |
| 81 | macromolecular complex remodeling (GO:0034367) | 3.90645746 |
| 82 | cholesterol efflux (GO:0033344) | 3.90223441 |
| 83 | alpha-amino acid catabolic process (GO:1901606) | 3.90117502 |
| 84 | positive regulation of coagulation (GO:0050820) | 3.89895192 |
| 85 | intestinal cholesterol absorption (GO:0030299) | 3.89048454 |
| 86 | glutamate metabolic process (GO:0006536) | 3.88531322 |
| 87 | negative regulation of lipase activity (GO:0060192) | 3.87061643 |
| 88 | high-density lipoprotein particle remodeling (GO:0034375) | 3.81384747 |
| 89 | response to mercury ion (GO:0046689) | 3.79841400 |
| 90 | aromatic amino acid family metabolic process (GO:0009072) | 3.75207359 |
| 91 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.70309718 |
| 92 | xenobiotic metabolic process (GO:0006805) | 3.69219535 |
| 93 | primary alcohol catabolic process (GO:0034310) | 3.63765932 |
| 94 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62834212 |
| 95 | regulation of cholesterol esterification (GO:0010872) | 3.59453172 |
| 96 | negative regulation of complement activation (GO:0045916) | 3.59302693 |
| 97 | cellular ketone body metabolic process (GO:0046950) | 3.54484102 |
| 98 | steroid catabolic process (GO:0006706) | 3.50117059 |
| 99 | serine family amino acid biosynthetic process (GO:0009070) | 3.49147149 |
| 100 | exogenous drug catabolic process (GO:0042738) | 10.5590168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.11065392 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.05724347 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.89039300 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.80595953 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.23691643 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.85313978 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.31460000 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.29506645 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06279951 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.67513521 |
| 11 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.15723775 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.13175443 |
| 13 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.10800046 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.07457309 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3095197 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.88753902 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.68383147 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61762483 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42148079 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21954906 |
| 21 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.19656762 |
| 22 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15869925 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10723113 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04828850 |
| 25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01382314 |
| 26 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.97382566 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97028236 |
| 28 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96390577 |
| 29 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.95636325 |
| 30 | CBP_21632823_ChIP-Seq_H3396_Human | 0.95427386 |
| 31 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95153446 |
| 32 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.94536141 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.93431861 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.91969851 |
| 35 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91101621 |
| 36 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90189698 |
| 37 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89595778 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.88901149 |
| 39 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.86925991 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85841655 |
| 41 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84987450 |
| 42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84545484 |
| 43 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.82750769 |
| 44 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81123881 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80700043 |
| 46 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80657512 |
| 47 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.79720740 |
| 48 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.77289083 |
| 49 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76980042 |
| 50 | AR_20517297_ChIP-Seq_VCAP_Human | 0.76573463 |
| 51 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.76198051 |
| 52 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.75284154 |
| 53 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74778909 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.73190899 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72204433 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.71625067 |
| 57 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.71344415 |
| 58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69503763 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.67594664 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.67418799 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.67249505 |
| 62 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.67241575 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66951301 |
| 64 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.66314758 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.65793371 |
| 66 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.64047417 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 0.63796960 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.63255962 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63157703 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63157703 |
| 71 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.62383341 |
| 72 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.62221940 |
| 73 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.61906695 |
| 74 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.61378383 |
| 75 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.59979238 |
| 76 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.59520959 |
| 77 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.59101189 |
| 78 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.58637554 |
| 79 | NFYB_21822215_ChIP-Seq_K562_Human | 0.57850774 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.57514356 |
| 81 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.57501264 |
| 82 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.56514470 |
| 83 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.56451684 |
| 84 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.56144562 |
| 85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.56057204 |
| 86 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.54805774 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.54526083 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.54034248 |
| 89 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.53662721 |
| 90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.53042803 |
| 91 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.52722296 |
| 92 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.52596512 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.52489608 |
| 94 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.52429486 |
| 95 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.52372267 |
| 96 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52172616 |
| 97 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.52155650 |
| 98 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.51297348 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.48685061 |
| 100 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.48510282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005085_abnormal_gallbladder_physiolo | 6.42335027 |
| 2 | MP0005360_urolithiasis | 5.91123700 |
| 3 | MP0005365_abnormal_bile_salt | 5.87314936 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.66676276 |
| 5 | MP0003195_calcinosis | 4.73544457 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 4.60705679 |
| 7 | MP0003252_abnormal_bile_duct | 4.50695792 |
| 8 | MP0003868_abnormal_feces_composition | 3.39325065 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.27418183 |
| 10 | MP0009697_abnormal_copulation | 2.83938263 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.72402548 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.44607280 |
| 13 | MP0005332_abnormal_amino_acid | 2.28800428 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.12022336 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 10.2883809 |
| 16 | MP0009840_abnormal_foam_cell | 1.96320939 |
| 17 | MP0002876_abnormal_thyroid_physiology | 1.93478107 |
| 18 | MP0000609_abnormal_liver_physiology | 1.86041981 |
| 19 | MP0010368_abnormal_lymphatic_system | 1.66582416 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.65581230 |
| 21 | MP0001764_abnormal_homeostasis | 1.56485306 |
| 22 | MP0001661_extended_life_span | 1.47556009 |
| 23 | MP0005408_hypopigmentation | 1.35664674 |
| 24 | MP0009053_abnormal_anal_canal | 1.29983101 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.17463279 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.14224516 |
| 27 | MP0005670_abnormal_white_adipose | 1.09665749 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.07317331 |
| 29 | MP0000598_abnormal_liver_morphology | 1.04726616 |
| 30 | MP0002132_abnormal_respiratory_system | 1.03588400 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03239450 |
| 32 | MP0005451_abnormal_body_composition | 1.03234668 |
| 33 | MP0009643_abnormal_urine_homeostasis | 0.94004745 |
| 34 | MP0009764_decreased_sensitivity_to | 0.87501963 |
| 35 | MP0009763_increased_sensitivity_to | 0.85595596 |
| 36 | MP0003186_abnormal_redox_activity | 0.82413824 |
| 37 | MP0005187_abnormal_penis_morphology | 0.81896785 |
| 38 | MP0005376_homeostasis/metabolism_phenot | 0.81156680 |
| 39 | MP0001915_intracranial_hemorrhage | 0.80848854 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.80645875 |
| 41 | MP0008469_abnormal_protein_level | 0.80095165 |
| 42 | MP0000604_amyloidosis | 0.76952460 |
| 43 | MP0002282_abnormal_trachea_morphology | 0.75882056 |
| 44 | MP0002971_abnormal_brown_adipose | 0.74566122 |
| 45 | MP0003690_abnormal_glial_cell | 0.74477446 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 0.68746458 |
| 47 | MP0003011_delayed_dark_adaptation | 0.67707087 |
| 48 | MP0005395_other_phenotype | 0.64621830 |
| 49 | MP0005464_abnormal_platelet_physiology | 0.64291228 |
| 50 | MP0005535_abnormal_body_temperature | 0.63652213 |
| 51 | MP0008872_abnormal_physiological_respon | 0.60743318 |
| 52 | MP0005266_abnormal_metabolism | 0.60100378 |
| 53 | MP0003638_abnormal_response/metabolism_ | 0.58415980 |
| 54 | MP0002168_other_aberrant_phenotype | 0.57541872 |
| 55 | MP0005023_abnormal_wound_healing | 0.56989051 |
| 56 | MP0003879_abnormal_hair_cell | 0.55605918 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 0.55227022 |
| 58 | MP0002249_abnormal_larynx_morphology | 0.54841344 |
| 59 | MP0008874_decreased_physiological_sensi | 0.54351245 |
| 60 | MP0005334_abnormal_fat_pad | 0.49365975 |
| 61 | MP0004130_abnormal_muscle_cell | 0.46142184 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 0.44666664 |
| 63 | MP0009785_altered_susceptibility_to | 0.40320145 |
| 64 | MP0005164_abnormal_response_to | 0.39821792 |
| 65 | MP0000249_abnormal_blood_vessel | 0.37196312 |
| 66 | MP0004883_abnormal_blood_vessel | 0.36340487 |
| 67 | MP0009765_abnormal_xenobiotic_induced | 0.36173804 |
| 68 | MP0005647_abnormal_sex_gland | 0.32585083 |
| 69 | MP0001851_eye_inflammation | 0.32095045 |
| 70 | MP0000467_abnormal_esophagus_morphology | 0.32021405 |
| 71 | MP0003959_abnormal_lean_body | 0.30070906 |
| 72 | MP0005166_decreased_susceptibility_to | 0.29940476 |
| 73 | MP0005448_abnormal_energy_balance | 0.29646251 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 0.29562466 |
| 75 | MP0005058_abnormal_lysosome_morphology | 0.29240074 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.29105422 |
| 77 | MP0004782_abnormal_surfactant_physiolog | 0.27703933 |
| 78 | MP0005197_abnormal_uvea_morphology | 0.27015132 |
| 79 | MP0002332_abnormal_exercise_endurance | 0.26806933 |
| 80 | MP0002928_abnormal_bile_duct | 0.26022549 |
| 81 | MP0003075_altered_response_to | 0.23927106 |
| 82 | MP0003953_abnormal_hormone_level | 0.23743878 |
| 83 | MP0003718_maternal_effect | 0.23406397 |
| 84 | MP0003705_abnormal_hypodermis_morpholog | 0.23403625 |
| 85 | MP0000566_synostosis | 0.21960913 |
| 86 | MP0008873_increased_physiological_sensi | 0.21707994 |
| 87 | MP0000639_abnormal_adrenal_gland | 0.21425850 |
| 88 | MP0009115_abnormal_fat_cell | 0.21321896 |
| 89 | MP0003632_abnormal_nervous_system | 0.21285461 |
| 90 | MP0001756_abnormal_urination | 0.21249132 |
| 91 | MP0001881_abnormal_mammary_gland | 0.21182066 |
| 92 | MP0001845_abnormal_inflammatory_respons | 0.20505127 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.19342344 |
| 94 | MP0004142_abnormal_muscle_tone | 0.18787199 |
| 95 | MP0002128_abnormal_blood_circulation | 0.18273164 |
| 96 | MP0000920_abnormal_myelination | 0.18181180 |
| 97 | MP0003633_abnormal_nervous_system | 0.16249014 |
| 98 | MP0001545_abnormal_hematopoietic_system | 0.15702893 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.15702893 |
| 100 | MP0001944_abnormal_pancreas_morphology | 0.14640248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.95590954 |
| 2 | Complement deficiency (HP:0004431) | 9.82052491 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 8.95195338 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.01284975 |
| 5 | Abnormality of complement system (HP:0005339) | 7.95241409 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 7.85112824 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 6.08631983 |
| 8 | Joint hemorrhage (HP:0005261) | 6.07906958 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 5.93542939 |
| 10 | * Conjugated hyperbilirubinemia (HP:0002908) | 5.61859127 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 5.46293425 |
| 12 | Glomerulonephritis (HP:0000099) | 5.38996101 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 5.16984103 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.84925553 |
| 15 | Xanthomatosis (HP:0000991) | 4.72035083 |
| 16 | Spontaneous abortion (HP:0005268) | 4.67961163 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.57007259 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.51991468 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 4.12207492 |
| 20 | Nephritis (HP:0000123) | 4.03919656 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.00753749 |
| 22 | Fat malabsorption (HP:0002630) | 3.79279566 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.63095171 |
| 24 | Hyperglycinemia (HP:0002154) | 3.48632494 |
| 25 | Generalized aminoaciduria (HP:0002909) | 3.38387669 |
| 26 | Hyperammonemia (HP:0001987) | 3.30728964 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.22686877 |
| 28 | Gingival bleeding (HP:0000225) | 3.18197085 |
| 29 | Rickets (HP:0002748) | 3.13246022 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.08938683 |
| 31 | Osteomalacia (HP:0002749) | 3.05647881 |
| 32 | Hypercholesterolemia (HP:0003124) | 2.99880217 |
| 33 | Mitral stenosis (HP:0001718) | 2.92439584 |
| 34 | Steatorrhea (HP:0002570) | 2.91911892 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.91021679 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 2.91021679 |
| 37 | Vascular calcification (HP:0004934) | 2.85803490 |
| 38 | Delayed CNS myelination (HP:0002188) | 2.85385461 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 2.75433044 |
| 40 | Epidermoid cyst (HP:0200040) | 2.73371685 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.71522514 |
| 42 | Thrombophlebitis (HP:0004418) | 2.68041470 |
| 43 | Fair hair (HP:0002286) | 2.63932277 |
| 44 | Hemorrhage of the eye (HP:0011885) | 2.63424592 |
| 45 | Hyperglycinuria (HP:0003108) | 2.59173378 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.54891260 |
| 47 | Cardiovascular calcification (HP:0011915) | 2.53106891 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.52884554 |
| 49 | Purpura (HP:0000979) | 2.43863934 |
| 50 | Neonatal hypoglycemia (HP:0001998) | 2.42610310 |
| 51 | Pulmonary embolism (HP:0002204) | 2.39541322 |
| 52 | Cholelithiasis (HP:0001081) | 2.32472638 |
| 53 | Hyperphosphaturia (HP:0003109) | 2.31568271 |
| 54 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.28207474 |
| 55 | Reduced antithrombin III activity (HP:0001976) | 2.26368089 |
| 56 | * Hyperbilirubinemia (HP:0002904) | 2.24321281 |
| 57 | Abnormality of vitamin metabolism (HP:0100508) | 2.20601631 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.20234200 |
| 59 | Abnormal gallbladder physiology (HP:0012438) | 2.19393370 |
| 60 | Cholecystitis (HP:0001082) | 2.19393370 |
| 61 | Menorrhagia (HP:0000132) | 2.17764315 |
| 62 | Elevated alkaline phosphatase (HP:0003155) | 2.17488725 |
| 63 | Metabolic acidosis (HP:0001942) | 2.14840337 |
| 64 | Glycosuria (HP:0003076) | 2.11798984 |
| 65 | Abnormality of urine glucose concentration (HP:0011016) | 2.11798984 |
| 66 | Myocardial infarction (HP:0001658) | 2.03630534 |
| 67 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.01510804 |
| 68 | Bifid scrotum (HP:0000048) | 2.00298673 |
| 69 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.3570324 |
| 70 | Joint swelling (HP:0001386) | 1.99301226 |
| 71 | Irritability (HP:0000737) | 1.98919731 |
| 72 | Arthropathy (HP:0003040) | 1.96089018 |
| 73 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.95433943 |
| 74 | Ketosis (HP:0001946) | 1.92694977 |
| 75 | Hypophosphatemic rickets (HP:0004912) | 1.91985086 |
| 76 | Abnormality of the Achilles tendon (HP:0005109) | 1.89630066 |
| 77 | Increased mean platelet volume (HP:0011877) | 1.87086070 |
| 78 | Abnormal urine phosphate concentration (HP:0012599) | 1.85606456 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 1.82315054 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 1.82265437 |
| 81 | Generalized hypopigmentation of hair (HP:0011358) | 1.82081091 |
| 82 | Increased serum ferritin (HP:0003281) | 1.80007996 |
| 83 | Bile duct proliferation (HP:0001408) | 1.79909935 |
| 84 | Abnormal biliary tract physiology (HP:0012439) | 1.79909935 |
| 85 | Poikilocytosis (HP:0004447) | 1.74383383 |
| 86 | Abnormality of purine metabolism (HP:0004352) | 1.73712788 |
| 87 | Epistaxis (HP:0000421) | 1.71283251 |
| 88 | Abnormal platelet volume (HP:0011876) | 1.68679651 |
| 89 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.66917941 |
| 90 | Gangrene (HP:0100758) | 1.66593897 |
| 91 | Cerebral palsy (HP:0100021) | 1.63675741 |
| 92 | Blue irides (HP:0000635) | 1.62911178 |
| 93 | Hydroxyprolinuria (HP:0003080) | 1.59568142 |
| 94 | Abnormality of proline metabolism (HP:0010907) | 1.59568142 |
| 95 | Skin nodule (HP:0200036) | 1.58570625 |
| 96 | Lethargy (HP:0001254) | 1.58532403 |
| 97 | Abnormality of the gallbladder (HP:0005264) | 1.58517032 |
| 98 | Abnormal delivery (HP:0001787) | 1.52613116 |
| 99 | Alkalosis (HP:0001948) | 1.51810729 |
| 100 | Pancreatitis (HP:0001733) | 1.51245259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 4.78753395 |
| 2 | ERN1 | 4.51814504 |
| 3 | FGFR4 | 3.67384209 |
| 4 | RIPK1 | 2.98959333 |
| 5 | TYK2 | 2.76140700 |
| 6 | PRKACG | 2.39964479 |
| 7 | EPHA3 | 2.30528408 |
| 8 | SIK1 | 2.30046263 |
| 9 | PIK3CA | 2.29387971 |
| 10 | MST1R | 2.17484478 |
| 11 | MAP3K3 | 2.06580744 |
| 12 | MAP2K4 | 2.05029094 |
| 13 | BCKDK | 2.04038397 |
| 14 | TRIB3 | 2.03791322 |
| 15 | PRPF4B | 2.01597211 |
| 16 | PRKAA2 | 1.90368452 |
| 17 | FGFR3 | 1.87190097 |
| 18 | NEK9 | 1.80393989 |
| 19 | MAPK11 | 1.74889358 |
| 20 | NTRK3 | 1.70654253 |
| 21 | PRKCG | 1.51953863 |
| 22 | IGF1R | 1.51510851 |
| 23 | TBK1 | 1.50739545 |
| 24 | ABL2 | 1.43969180 |
| 25 | JAK1 | 1.41798052 |
| 26 | MAP3K2 | 1.29315917 |
| 27 | JAK2 | 1.26954603 |
| 28 | PINK1 | 1.26874907 |
| 29 | CAMKK2 | 1.25905360 |
| 30 | NLK | 1.25574042 |
| 31 | IRAK3 | 1.23534566 |
| 32 | MAP2K3 | 1.17841285 |
| 33 | PDPK1 | 1.15777323 |
| 34 | ERBB2 | 1.14346792 |
| 35 | TNK2 | 1.09620092 |
| 36 | FER | 1.08036716 |
| 37 | PRKCZ | 1.07263263 |
| 38 | EPHA4 | 1.06464747 |
| 39 | TAOK3 | 1.04459911 |
| 40 | MET | 1.01968741 |
| 41 | MAP3K12 | 1.01624811 |
| 42 | CDK6 | 0.98046580 |
| 43 | PRKAA1 | 0.97719874 |
| 44 | PRKG1 | 0.96071877 |
| 45 | MYLK | 0.93895741 |
| 46 | FRK | 0.92882220 |
| 47 | PRKACA | 0.88844585 |
| 48 | EPHB1 | 0.87718324 |
| 49 | SCYL2 | 0.87439038 |
| 50 | ERBB4 | 0.84850771 |
| 51 | CSF1R | 0.82545756 |
| 52 | RET | 0.81466510 |
| 53 | BRSK2 | 0.80068429 |
| 54 | PDK1 | 0.79628395 |
| 55 | ZAP70 | 0.78991457 |
| 56 | ICK | 0.75935429 |
| 57 | CSNK1D | 0.74294876 |
| 58 | MAP3K6 | 0.73231202 |
| 59 | ACVR1B | 0.72694645 |
| 60 | MAP3K1 | 0.72642908 |
| 61 | DYRK1B | 0.71083966 |
| 62 | INSRR | 0.66813617 |
| 63 | SGK3 | 0.66559892 |
| 64 | CSNK1E | 0.65700383 |
| 65 | PRKCB | 0.65130819 |
| 66 | PRKCA | 0.64713081 |
| 67 | SGK494 | 0.63202307 |
| 68 | SGK223 | 0.63202307 |
| 69 | RPS6KA3 | 0.62415677 |
| 70 | SGK2 | 0.59835760 |
| 71 | MAP3K5 | 0.58258924 |
| 72 | KSR2 | 0.58062059 |
| 73 | AKT3 | 0.57704447 |
| 74 | MAP3K13 | 0.57303644 |
| 75 | PRKACB | 0.57276876 |
| 76 | BCR | 0.56523900 |
| 77 | GRK1 | 0.56276713 |
| 78 | SGK1 | 0.53746168 |
| 79 | TIE1 | 0.52879462 |
| 80 | DAPK2 | 0.49420652 |
| 81 | SRC | 0.48851456 |
| 82 | GSK3A | 0.48247748 |
| 83 | WNK3 | 0.47050579 |
| 84 | PTK6 | 0.46150853 |
| 85 | TAOK2 | 0.45642010 |
| 86 | MAPK4 | 0.45237610 |
| 87 | PKN2 | 0.44116470 |
| 88 | CSNK2A1 | 0.42715748 |
| 89 | CAMK2G | 0.41947134 |
| 90 | CAMKK1 | 0.41798262 |
| 91 | MAP3K11 | 0.39738815 |
| 92 | TGFBR2 | 0.37531920 |
| 93 | STK38 | 0.37391960 |
| 94 | CAMK1D | 0.37232661 |
| 95 | PDK2 | 0.36896439 |
| 96 | MAPK7 | 0.36738492 |
| 97 | CSNK1A1 | 0.36389260 |
| 98 | CDK9 | 0.35537293 |
| 99 | RPS6KB1 | 0.35279099 |
| 100 | MAPK12 | 0.35057823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.55471486 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.02364418 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.92791111 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.78085842 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.70199383 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.55155991 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 3.54311916 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.01002658 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.00266162 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.83684581 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.75055175 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.72981473 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58027821 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44320981 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39047107 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.25949474 |
| 17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.21885517 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10234601 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.05926843 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.92517196 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.88368350 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87639344 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85433576 |
| 24 | * Bile secretion_Homo sapiens_hsa04976 | 1.67836348 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61704851 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56278022 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.38674954 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33699139 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.32077423 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.31032552 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.29337112 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27055033 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.26143071 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.24148595 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20771337 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.17830499 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16106136 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.11003219 |
| 39 | Prion diseases_Homo sapiens_hsa05020 | 1.10222694 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02177535 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.01831478 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.00877769 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92114251 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88159495 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 0.85026395 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81417292 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80059975 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78326041 |
| 49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77531981 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77395059 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75397257 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72261398 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69767013 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65444387 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60150451 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.51845516 |
| 57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41230393 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40556613 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32622591 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.29009581 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26216259 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25583303 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23272961 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.18776620 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.18179738 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15004689 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.12902690 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12549460 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.10909036 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.09840831 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.09314260 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08815948 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.06292784 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.05421770 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05332946 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.03859210 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.03433082 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.01339340 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2914670 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2732475 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2677309 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2547991 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2471953 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2438114 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2172819 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2120950 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2046508 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1891353 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1797035 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1438879 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1392977 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | -0.1385813 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1362338 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1229741 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0879791 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0853619 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | -0.0596620 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0292730 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0291548 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0211285 |

